CVS HEALTH CORPORATION Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval
CVS HEALTH CORPORATION (CVS) had Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval of $3.79 billion as of 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Equity
us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval · last filed 2026-02-10
- 2025-12-31: Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval $3.79B.
- 2024-12-31: Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval $1.56B.
- 2023-12-31: Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval $3.10B.
- 2022-12-31: Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval $2.71B.
| Period end | Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval | Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval as first filed |
|---|---|---|
| 2025-12-31 | $3.79B 10-K · filed 2026-02-10 | |
| 2024-12-31 | $1.56B 10-K · filed 2025-02-12 | |
| 2023-12-31 | $3.10B 10-K · filed 2024-02-07 | |
| 2022-12-31 | $2.71B 8-K · filed 2023-05-25 | |
| 2021-12-31 | $2.94B 10-K · filed 2022-02-09 | |
| 2020-12-31 | $2.90B 10-K · filed 2021-02-16 | |
| 2019-12-31 | $366.00M 10-K · filed 2020-02-18 | |
| 2018-12-31 | $480.00M 8-K · filed 2019-08-08 | $584.00M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |